Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.
about
European guidance for the diagnosis and management of osteoporosis in postmenopausal womenFRAX and the assessment of fracture probability in men and women from the UKThe evolution of selective estrogen receptor modulators in osteoporosis therapyIdentification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meetingOsteoporotic vertebral compression fractures and vertebral augmentation.The Role of Water Compartments in the Material Properties of Cortical BoneHigh incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapyPrevalent morphometric vertebral fractures in professional male rugby players.Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosisUndiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parametersAnatomical distribution of vertebral fractures: comparison of pediatric and adult spines.Simplified criteria for selecting patients for vertebral fracture assessment.Methods and reliability of radiographic vertebral fracture detection in older men: the osteoporotic fractures in men study.Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update.Using clinical risk factors and bone mineral density to determine who among patients undergoing bone densitometry should have vertebral fracture assessment.Appropriate use of anabolic treatment for severe osteoporosisClinical risk factor assessment had better discriminative ability than bone mineral density in identifying subjects with vertebral fractureEstrogens and Androgens in Skeletal Physiology and Pathophysiology.Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations.Treatment of osteopenia.Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene.Updated recommendations for the diagnosis and management of osteoporosis: a local perspectiveAlendronate and raloxifene therapy in the early period after hip fractureDesigning the ideal selective estrogen receptor modulator--an achievable goal?SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.Prevalence of vertebral fractures on chest radiographs of elderly African American and Caucasian women.Radiographic texture analysis of densitometric calcaneal images: relationship to clinical characteristics and to bone fragility.Time and dose-dependent effects of Labisia pumila on the bone strength of postmenopausal osteoporosis rat model.Vertebral augmentation treatment of painful osteoporotic compression fractures with the Kiva VCF Treatment SystemDeterminants of the mechanical behavior of human lumbar vertebrae after simulated mild fracture.Recognition of morphometric vertebral fractures by artificial neural networks: analysis from GISMO Lombardia Database.Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.Relationships between vertebral fractures, sex hormones and vitamin D in Moroccan postmenopausal women: a cross sectional studyEthnic difference of clinical vertebral fracture risk.Domino Effect: mechanic factors role.A review of teriparatide and its clinical efficacy in the treatment of osteoporosis.Risk factors for prevalent vertebral fractures in black and white female densitometry patients.Management of severe osteoporosis.A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men.Initial non-weight-bearing therapy is important for preventing vertebral body collapse in elderly patients with clinical vertebral fractures.
P2860
Q24612411-758405CA-C834-4183-8C9D-8F42275A350FQ24654123-61FAA5A3-4A9F-4F2D-A041-3CDAF7952D3CQ26827973-4EEECD1E-0B41-4A4B-8BA7-1F69FA545798Q30234621-7A2D802B-D97C-4C43-91DD-B9CC2A5270A5Q30433227-625221BB-E96B-42E2-8D78-534F9D76AE62Q30911933-8B12B5AF-D881-4CF6-A510-5A72BBE88136Q33618291-ACE4F978-1254-4A6A-A121-137FFD92BE95Q33638217-394F9D2B-5718-4F7A-B567-392825FA1C6AQ33663460-1C5F8E92-A6F3-4D9B-B333-A9F322F272E9Q33722188-D8C40AB8-D55A-4E3D-8730-33F6A3DAEF46Q33793850-CB0683B4-0FE1-4B53-B4A8-D95967C4D4EFQ34001425-37DFFD31-4E76-4098-99FF-5EFDECB5D004Q34121235-971C20AD-6129-4C4B-9401-F8C0ABF14904Q34272056-C98D46E7-15CA-4A0E-AD9F-EDF7E5A8E880Q34283994-31804277-A018-42FB-95AC-0B137464B872Q34417198-A37C4F8C-68CE-43BA-AEC8-35A8ECD3B6D9Q34486736-C5F7E89C-8B2C-4115-88B3-07FFCA4FB516Q34543980-6C9EE153-5808-4AC5-9006-CAF626ADEE65Q34613087-96DF07C0-E043-4AB9-BD03-9E890F6B9CDBQ34630644-02D23D1B-9031-4479-8790-57E09410281FQ34896573-FD4A5F13-E12E-43C6-AA78-3EE146FCE2EAQ35008617-0FCAE6B4-6311-4ED7-B28E-A39CA8836BCEQ35022755-FB1DA1E4-5D69-4BD2-B3BB-9CCF8BD3459BQ35023776-471C80E0-E281-44F3-BAE5-FA7DCD9E5349Q35028647-42173AE1-F3D1-4814-8831-7BAB2EBA6A51Q35093990-A640142E-D08E-45DF-9474-40C150A55BE2Q35156032-D62C2D80-D274-4CDF-A779-C12E588F039FQ35191452-BD4E763C-D269-4B2D-BE0F-3DE493DF039FQ35194309-90E11C16-F43B-48E1-A7B7-923EC439F929Q35229984-E59C424A-DF8B-4C53-8C25-31507AA77214Q35528208-43DFB358-F91D-4E0C-985A-57D4AB833C03Q35593300-647E4AD8-E603-4B12-8281-7738CA318E67Q35618976-79B25B0D-D144-48FA-8BAD-8FD7F07614EDQ35751453-18242A24-5A23-40ED-813A-639C5A6D41B1Q35755710-E49852B7-5E30-4EC2-B4E5-87D3EC19655DQ35779222-AB40BD32-7895-43DB-8976-E333BADB380FQ35838962-964C24CB-6BCB-4CC6-87A6-70CBC3E72AE7Q35852252-DF77649F-CF58-4582-A334-8F29DBD95E56Q35897285-35F8888B-FED7-4671-B074-48835A863EEBQ35940156-DBBB2E05-C150-45CC-849D-C7629B8F48CC
P2860
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Severity of prevalent vertebra ...... : results from the MORE trial.
@en
Severity of prevalent vertebra ...... : results from the MORE trial.
@nl
type
label
Severity of prevalent vertebra ...... : results from the MORE trial.
@en
Severity of prevalent vertebra ...... : results from the MORE trial.
@nl
prefLabel
Severity of prevalent vertebra ...... : results from the MORE trial.
@en
Severity of prevalent vertebra ...... : results from the MORE trial.
@nl
P2093
P1433
P1476
Severity of prevalent vertebra ...... : results from the MORE trial.
@en
P2093
P304
P356
10.1016/S8756-3282(03)00241-2
P577
2003-10-01T00:00:00Z